UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~June 30, 2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 000-49604

ManTech International Corporation

(Exact Name of Registrant as Specified in its Charter)


Delaware			22-1852179
State or Other Jurisdiction of Incorporation or Organization			I.R.S. Employer Identification No.

2251 Corporate Park Drive	Herndon	VA	20171
Address of Principal Executive Offices			Zip Code

(703) 218-6000

Registrant’s Telephone Number, Including Area Code

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock	MANT	Nasdaq

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~May 3,~~August 1, 2022 there were ~~39,355,500~~39,382,197 shares outstanding of our Class A common stock and ~~1,596,695~~1,586,695 shares outstanding of our Class B common stock.

TABLE OF CONTENTS


		Page No.
PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Balance Sheets as of ~~March 31,~~June 30, 2022 and December 31, 2021	3
	Condensed Consolidated Statements of Income for the Three and Six Months Ended ~~March 31,~~June 30, 2022 and 2021	4
	Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended ~~March 31,~~June 30, 2022 and 2021	5
	Condensed Consolidated Statements of Changes in Stockholders' Equity for the Three and Six Months Ended ~~March 31,~~June 30, 2022 and 2021	6
	Condensed Consolidated Statements of Cash Flows for the ~~Three~~Six Months Ended ~~March 31,~~June 30, 2022 and 2021	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	1617
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	2123
Item 4.	Controls and Procedures	2123
Part II - OTHER INFORMATION
Item 1.	Legal Proceedings	2225
Item 1A.	Risk Factors	25
Item 6.	Exhibits	2227

PART I – FINANCIAL INFORMATION

Item 1.Financial Statements

MANTECH INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands Except Share and Per Share Amounts)


		(unaudited)					(unaudited)
		March 31, 2022		December 31, 2021			June 30, 2022		December 31, 2021
ASSETS	ASSETS					ASSETS
Cash and cash equivalents	Cash and cash equivalents	$	60,286	$	53,374	Cash and cash equivalents	$	46,751	$	53,374
Receivables—net	Receivables—net	471,106		476,035		Receivables—net	511,481		476,035
Prepaid expenses	Prepaid expenses	38,510		32,600		Prepaid expenses	41,975		32,600
Taxes receivable—current	Taxes receivable—current	9,657		22,140		Taxes receivable—current	19,975		22,140
Other current assets	Other current assets	14,260		13,372		Other current assets	8,779		13,372
Total Current Assets	Total Current Assets	593,819		597,521		Total Current Assets	628,961		597,521
Goodwill	Goodwill	1,509,259		1,498,988		Goodwill	1,511,068		1,498,988
Other intangible assets—net	Other intangible assets—net	252,344		265,555		Other intangible assets—net	244,338		265,555
Property and equipment—net	Property and equipment—net	136,104		133,297		Property and equipment—net	132,978		133,297
Operating lease right of use assets	Operating lease right of use assets	79,973		75,319		Operating lease right of use assets	74,233		75,319
Employee supplemental savings plan assets	Employee supplemental savings plan assets	35,286		43,342		Employee supplemental savings plan assets	30,792		43,342
Investments	Investments	11,555		11,555		Investments	11,555		11,555
Other assets	Other assets	15,820		13,988		Other assets	14,647		13,988
TOTAL ASSETS	TOTAL ASSETS	$	2,634,160	$	2,639,565	TOTAL ASSETS	$	2,648,572	$	2,639,565
LIABILITIES AND STOCKHOLDERS' EQUITY	LIABILITIES AND STOCKHOLDERS' EQUITY					LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES	LIABILITIES					LIABILITIES
Accounts payable	Accounts payable	$	158,973	$	169,140	Accounts payable	$	162,193	$	169,140
Accrued salaries and related expenses	Accrued salaries and related expenses	124,098		129,685		Accrued salaries and related expenses	130,562		129,685
Contract liabilities						Contract liabilities	34,638		36,197
Operating lease obligations—current	Operating lease obligations—current	32,118		32,557		Operating lease obligations—current	31,007		32,557
Contract liabilities		30,320		36,197
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	11,691		9,649		Accrued expenses and other current liabilities	13,108		9,649
Total Current Liabilities	Total Current Liabilities	357,200		377,228		Total Current Liabilities	371,508		377,228
Long-term debt	Long-term debt	300,000		300,000		Long-term debt	300,000		300,000
Deferred income taxes	Deferred income taxes	170,520		174,060		Deferred income taxes	168,350		174,060
Operating lease obligations—long term	Operating lease obligations—long term	69,300		63,575		Operating lease obligations—long term	63,433		63,575
Accrued retirement	Accrued retirement	29,701		36,053		Accrued retirement	25,876		36,053
Other long-term liabilities	Other long-term liabilities	13,142		13,229		Other long-term liabilities	13,520		13,229
TOTAL LIABILITIES	TOTAL LIABILITIES	939,863		964,145		TOTAL LIABILITIES	942,687		964,145
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES	0		0		COMMITMENTS AND CONTINGENCIES	0		0
STOCKHOLDERS' EQUITY	STOCKHOLDERS' EQUITY					STOCKHOLDERS' EQUITY
Common stock, Class A—$0.01 par value; 150,000,000 shares authorized; 39,594,756 and 27,863,041 shares issued at March 31, 2022 and December 31, 2021; 39,350,643 and 27,618,928 shares outstanding at March 31, 2022 and December 31, 2021		396		279
Common stock, Class B—$0.01 par value; 50,000,000 shares authorized; 1,596,695 and 13,176,695 shares issued and outstanding at March 31, 2022 and December 31, 2021		16		132
Common stock, Class A—$0.01 par value; 150,000,000 shares authorized; 39,624,611 and 27,863,041 shares issued at June 30, 2022 and December 31, 2021; 39,380,498 and 27,618,928 shares outstanding at June 30, 2022 and December 31, 2021						Common stock, Class A—$0.01 par value; 150,000,000 shares authorized; 39,624,611 and 27,863,041 shares issued at June 30, 2022 and December 31, 2021; 39,380,498 and 27,618,928 shares outstanding at June 30, 2022 and December 31, 2021	396		279
Common stock, Class B—$0.01 par value; 50,000,000 shares authorized; 1,586,695 and 13,176,695 shares issued and outstanding at June 30, 2022 and December 31, 2021						Common stock, Class B—$0.01 par value; 50,000,000 shares authorized; 1,586,695 and 13,176,695 shares issued and outstanding at June 30, 2022 and December 31, 2021	16		132
Additional paid-in capital	Additional paid-in capital	570,871		566,573		Additional paid-in capital	576,430		566,573
Treasury stock, 244,113 and 244,113 shares at cost at March 31, 2022 and December 31, 2021		(9,158)		(9,158)
Treasury stock, 244,113 and 244,113 shares at cost at June 30, 2022 and December 31, 2021						Treasury stock, 244,113 and 244,113 shares at cost at June 30, 2022 and December 31, 2021	(9,158)		(9,158)
Retained earnings	Retained earnings	1,132,457		1,117,867		Retained earnings	1,138,499		1,117,867
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(285)		(273)		Accumulated other comprehensive loss	(298)		(273)
TOTAL STOCKHOLDERS' EQUITY	TOTAL STOCKHOLDERS' EQUITY	1,694,297		1,675,420		TOTAL STOCKHOLDERS' EQUITY	1,705,885		1,675,420
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	2,634,160	$	2,639,565	TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	2,648,572	$	2,639,565

See notes to condensed consolidated financial statements.

MANTECH INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)


		(unaudited) Three months ended March 31,					(unaudited) Three months ended June 30,				(unaudited) Six months ended June 30,
		2022		2021			2022		2021		2022		2021
REVENUE	REVENUE	$	675,545	$	633,224	REVENUE	$	669,352	$	648,578	$	1,344,897	$	1,281,802
Cost of services	Cost of services	575,971		542,717		Cost of services	573,373		552,868		1,149,344		1,095,585
General and administrative expenses	General and administrative expenses	55,736		48,086		General and administrative expenses	61,054		47,048		116,790		95,134
OPERATING INCOME	OPERATING INCOME	43,838		42,421		OPERATING INCOME	34,925		48,662		78,763		91,083
Interest expense	Interest expense	(2,242)		(354)		Interest expense	(2,033)		(366)		(4,275)		(720)
Interest income	Interest income	53		40		Interest income	46		39		99		79
Other income (expense), net	Other income (expense), net	112		(121)		Other income (expense), net	(11)		(12)		101		(133)
INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	41,761		41,986		INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	32,927		48,323		74,688		90,309
Provision for income taxes	Provision for income taxes	(10,420)		(9,657)		Provision for income taxes	(10,090)		(11,714)		(20,510)		(21,371)
Equity in losses of unconsolidated subsidiaries	Equity in losses of unconsolidated subsidiaries	—		(1)		Equity in losses of unconsolidated subsidiaries	—		—		—		(1)
NET INCOME	NET INCOME	$	31,341	$	32,328	NET INCOME	$	22,837	$	36,609	$	54,178	$	68,937
BASIC EARNINGS PER SHARE:	BASIC EARNINGS PER SHARE:					BASIC EARNINGS PER SHARE:
Class A common stock	Class A common stock	$	0.77	$	0.80	Class A common stock	$	0.56	$	0.90	$	1.33	$	1.70
Class B common stock	Class B common stock	$	0.77	$	0.80	Class B common stock	$	0.56	$	0.90	$	1.33	$	1.70
DILUTED EARNINGS PER SHARE:	DILUTED EARNINGS PER SHARE:					DILUTED EARNINGS PER SHARE:
Class A common stock	Class A common stock	$	0.76	$	0.79	Class A common stock	$	0.55	$	0.89	$	1.32	$	1.68
Class B common stock	Class B common stock	$	0.76	$	0.79	Class B common stock	$	0.55	$	0.89	$	1.32	$	1.68

See notes to condensed consolidated financial statements.

MANTECH INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)


		(unaudited) Three months ended March 31,					(unaudited) Three months ended June 30,				(unaudited) Six months ended June 30,
		2022		2021			2022		2021		2022		2021
NET INCOME	NET INCOME	$	31,341	$	32,328	NET INCOME	$	22,837	$	36,609	$	54,178	$	68,937
OTHER COMPREHENSIVE LOSS:	OTHER COMPREHENSIVE LOSS:					OTHER COMPREHENSIVE LOSS:
Translation adjustments, net of tax	Translation adjustments, net of tax	(12)		(12)		Translation adjustments, net of tax	(13)		(7)		(25)		(19)
Total other comprehensive loss	Total other comprehensive loss	(12)		(12)		Total other comprehensive loss	(13)		(7)		(25)		(19)
COMPREHENSIVE INCOME	COMPREHENSIVE INCOME	$	31,329	$	32,316	COMPREHENSIVE INCOME	$	22,824	$	36,602	$	54,153	$	68,918

See notes to condensed consolidated financial statements.

MANTECH INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(In Thousands)


		(unaudited) Three months ended March 31,					(unaudited) Three months ended June 30,				(unaudited) Six months ended June 30,
		2022		2021			2022		2021		2022		2021
Common Stock, Class A	Common Stock, Class A					Common Stock, Class A
At beginning of period	At beginning of period	$	279	$	275	At beginning of period	$	396	$	277	$	279	$	275
Conversion Class B to Class A common stock	Conversion Class B to Class A common stock	116		—		Conversion Class B to Class A common stock	—		—		116		—
Stock-based compensation expense	Stock-based compensation expense	1		1		Stock-based compensation expense	—		—		1		1
Stock option exercises	Stock option exercises	—		1		Stock option exercises	—		1		—		2
At end of period	At end of period	396		277		At end of period	396		278		396		278
Common Stock, Class B	Common Stock, Class B					Common Stock, Class B
At beginning of period	At beginning of period	132		132		At beginning of period	16		132		132		132
Conversion Class B to Class A common stock	Conversion Class B to Class A common stock	(116)		—		Conversion Class B to Class A common stock	—		—		(116)		—
At end of period	At end of period	16		132		At end of period	16		132		16		132
Additional Paid-In Capital	Additional Paid-In Capital					Additional Paid-In Capital
At beginning of period	At beginning of period	566,573		545,717		At beginning of period	570,871		549,811		566,573		545,717
Stock-based compensation expense	Stock-based compensation expense	3,917		3,442		Stock-based compensation expense	4,428		4,113		8,345		7,555
Stock option exercises	Stock option exercises	4,010		3,141		Stock option exercises	1,142		3,291		5,152		6,432
Payment consideration to tax authority on employees' behalf	Payment consideration to tax authority on employees' behalf	(3,629)		(2,489)		Payment consideration to tax authority on employees' behalf	(11)		(4)		(3,640)		(2,493)
At end of period	At end of period	570,871		549,811		At end of period	576,430		557,211		576,430		557,211
Treasury Stock, at cost	Treasury Stock, at cost					Treasury Stock, at cost
At beginning of period	At beginning of period	(9,158)		(9,158)		At beginning of period	(9,158)		(9,158)		(9,158)		(9,158)
At end of period	At end of period	(9,158)		(9,158)		At end of period	(9,158)		(9,158)		(9,158)		(9,158)
Retained Earnings	Retained Earnings					Retained Earnings
At beginning of period	At beginning of period	1,117,867		1,042,676		At beginning of period	1,132,457		1,059,608		1,117,867		1,042,676
Net income	Net income	31,341		32,328		Net income	22,837		36,609		54,178		68,937
Dividends	Dividends	(16,751)		(15,396)		Dividends	(16,795)		(15,455)		(33,546)		(30,851)
At end of period	At end of period	1,132,457		1,059,608		At end of period	1,138,499		1,080,762		1,138,499		1,080,762
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss					Accumulated Other Comprehensive Loss
At beginning of period	At beginning of period	(273)		(230)		At beginning of period	(285)		(242)		(273)		(230)
Translation adjustments, net of tax	Translation adjustments, net of tax	(12)		(12)		Translation adjustments, net of tax	(13)		(7)		(25)		(19)
At end of period	At end of period	(285)		(242)		At end of period	(298)		(249)		(298)		(249)
Total Stockholders' Equity	Total Stockholders' Equity	$	1,694,297	$	1,600,428	Total Stockholders' Equity	$	1,705,885	$	1,628,976	$	1,705,885	$	1,628,976

See notes to condensed consolidated financial statements.

MANTECH INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)


		(unaudited) Three months ended March 31,					(unaudited) Six months ended June 30,
		2022		2021			2022		2021
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:	CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:					CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:
Net income	Net income	$	31,341	$	32,328	Net income	$	54,178	$	68,937
Adjustments to reconcile net income to net cash flows from operating activities:	Adjustments to reconcile net income to net cash flows from operating activities:					Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	Depreciation and amortization	21,951		19,152		Depreciation and amortization	41,963		37,887
Noncash lease expense	Noncash lease expense	7,473		8,023		Noncash lease expense	15,174		15,855
Stock-based compensation expense	Stock-based compensation expense	3,918		3,443		Stock-based compensation expense	8,346		7,556
Deferred income taxes	Deferred income taxes	(2,136)		1,462		Deferred income taxes	(4,099)		3,274
Contract loss reserve	Contract loss reserve	(527)		—		Contract loss reserve	(1,391)		—
Bad debt expense	Bad debt expense	(14)		(999)		Bad debt expense	(1,247)		(999)
Change in assets and liabilities—net of effects from acquired businesses:	Change in assets and liabilities—net of effects from acquired businesses:					Change in assets and liabilities—net of effects from acquired businesses:
Receivables-net	Receivables-net	3,220		(26,823)		Receivables-net	(33,158)		(56,912)
Prepaid expenses	Prepaid expenses	(7,822)		(3,960)		Prepaid expenses	(11,286)		(9,186)
Taxes receivable—current	Taxes receivable—current	12,259		7,629		Taxes receivable—current	1,941		5,247
Other current assets	Other current assets	1,759		1,295		Other current assets	6,336		401
Employee supplemental savings plan asset	Employee supplemental savings plan asset	3,056		(358)		Employee supplemental savings plan asset	7,192		(2,836)
Other assets	Other assets	(2,221)		(2,051)		Other assets	(1,315)		(2,415)
Accounts payable	Accounts payable	(10,420)		(19,862)		Accounts payable	(7,923)		30,392
Accrued salaries and related expenses	Accrued salaries and related expenses	(6,518)		(3,015)		Accrued salaries and related expenses	(54)		1,330
Contract liabilities	Contract liabilities	(6,351)		(6,386)		Contract liabilities	(2,033)		(6,159)
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	1,712		(4,963)		Accrued expenses and other current liabilities	245		(5,896)
Operating lease obligations	Operating lease obligations	(9,692)		(8,941)		Operating lease obligations	(18,733)		(17,573)
Accrued retirement	Accrued retirement	(6,352)		(3,750)		Accrued retirement	(10,177)		(1,977)
Other	Other	(160)		(404)		Other	(94)		(469)
Net cash flow from (used in) operating activities		34,476		(8,180)
Net cash flow from operating activities						Net cash flow from operating activities	43,865		66,457
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES:	CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES:					CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES:
Purchases of property and equipment	Purchases of property and equipment	(16,204)		(17,854)		Purchases of property and equipment	(23,409)		(31,077)
Proceeds from corporate owned life insurance	Proceeds from corporate owned life insurance	5,000		—		Proceeds from corporate owned life insurance	5,358		227
Net cash used in investing activities		(11,204)		(17,854)
Investments in capitalized software						Investments in capitalized software	(375)		—
Net cash (used in) investing activities						Net cash (used in) investing activities	(18,426)		(30,850)
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:	CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:					CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:
Borrowings under credit facility						Borrowings under credit facility	40,500		164,000
Repayments under credit facility						Repayments under credit facility	(40,500)		(149,000)
Dividends paid	Dividends paid	(16,741)		(15,388)		Dividends paid	(33,574)		(30,866)
Proceeds from exercise of stock options	Proceeds from exercise of stock options	4,010		3,142		Proceeds from exercise of stock options	5,152		6,433
Payment consideration to tax authority on employee's behalf	Payment consideration to tax authority on employee's behalf	(3,629)		(2,489)		Payment consideration to tax authority on employee's behalf	(3,640)		(2,493)
Borrowings under credit facility		2,000		131,000
Repayments under credit facility		(2,000)		(124,500)
Net cash from used in financing activities		(16,360)		(8,235)
Net cash (used in) financing activities						Net cash (used in) financing activities	(32,062)		(11,926)
NET CHANGE IN CASH AND CASH EQUIVALENTS	NET CHANGE IN CASH AND CASH EQUIVALENTS	6,912		(34,269)		NET CHANGE IN CASH AND CASH EQUIVALENTS	(6,623)		23,681
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	53,374		41,193		CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	53,374		41,193
CASH AND CASH EQUIVALENTS, END OF PERIOD	CASH AND CASH EQUIVALENTS, END OF PERIOD	$	60,286	$	6,924	CASH AND CASH EQUIVALENTS, END OF PERIOD	$	46,751	$	64,874
SUPPLEMENTAL CASH FLOW INFORMATION	SUPPLEMENTAL CASH FLOW INFORMATION					SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest	Cash paid for interest	$	2,159	$	327	Cash paid for interest	$	3,758	$	664
Cash paid for income taxes, net of refunds	Cash paid for income taxes, net of refunds	$	295	$	10	Cash paid for income taxes, net of refunds	$	22,348	$	12,864
Noncash investing and financing activities:	Noncash investing and financing activities:					Noncash investing and financing activities:
Operating lease obligations arising from obtaining right of use assets	Operating lease obligations arising from obtaining right of use assets	$	14,978	$	5,401	Operating lease obligations arising from obtaining right of use assets	$	17,041	$	9,496
Finance lease obligations arising from obtaining right of use assets	Finance lease obligations arising from obtaining right of use assets	$	—	$	62	Finance lease obligations arising from obtaining right of use assets	$	—	$	62
Noncash investing activities	Noncash investing activities	$	(643)	$	479	Noncash investing activities	$	(140)	$	(764)

See notes to condensed consolidated financial statements.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~March 31,~~June 30, 2022

UNAUDITED

1.Description of the Business

ManTech International Corporation (depending on the circumstances, “ManTech” “Company” “we” “our” “ours” or “us”) provides mission-focused technology solutions and services for U.S. defense, intelligence community and federal civilian agencies. We excel in full-spectrum cyber, data collection & analytics, enterprise information technology (IT) and systems engineering and software application development solutions that support national and homeland security.

2.Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and note disclosures normally included in the annual financial statements, prepared in accordance with accounting principles generally accepted in the U.S., have been condensed or omitted pursuant to those rules and regulations. The preparation of these condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses. We recommend that you read these condensed consolidated financial statements in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, previously filed with the SEC. We believe that the condensed consolidated financial statements in this Form 10-Q reflect all adjustments that are necessary to fairly present the financial position, results of operations and cash flows for the interim periods presented. The results of operations for such interim periods are not necessarily indicative of the results that can be expected for the full year.

3.Proposed Merger

On May 13, 2022 the Company entered into an Agreement and Plan of Merger (the Merger Agreement) with Moose Bidco, Inc., a Delaware corporation (Parent), and Moose Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (Merger Sub). Pursuant to the Merger Agreement, and in accordance with the terms and subject to the conditions thereof, Merger Sub will merge with and into the Company (the Merger), with the Company surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, the Company will be acquired by Parent, which will be controlled by investment funds managed by The Carlyle Group Inc.

ManTech’s Board of Directors has unanimously determined that the transactions contemplated by the Merger Agreement, including the Merger, are in the best interests of the Company and its stockholders, and approved the Merger Agreement and the transactions contemplated by the Merger Agreement. Our Board of Directors has also unanimously resolved to recommend that the Company’s stockholders vote to adopt the Merger Agreement and approve the Merger and other transactions contemplated thereby.

Under the Merger Agreement, in accordance with the terms and subject to the conditions set forth therein, at the effective time of the Merger, each issued and outstanding share of Class A Common Stock, par value $0.01 per share, of the Company and Class B Common Stock, par value $0.01 per share, of the Company will be automatically converted into the right to receive $96.00 in cash, without interest, other than (1) those shares owned by Parent, Merger Sub or the Company (as treasury stock or otherwise) or any of their respective wholly owned subsidiaries (which will be cancelled without any consideration) and (2) any shares as to which appraisal rights have been properly exercised, and not withdrawn, in accordance with the Delaware General Corporation Law.

The consummation of the merger is subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement, including, among others, (1) the adoption of the Merger Agreement by the Company’s stockholders, (2) the expiration or termination of any waiting period (and any extension thereof) applicable under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the HSR Act which expired June 20, 2022), (3) the absence of any law or order by a governmental authority that has the effect of preventing, making illegal or prohibiting the consummation of the Merger or any other transaction contemplated by the Merger Agreement and (4) the absence of a “Company Material Adverse Effect” (as defined in the Merger Agreement). The consummation of the Merger is not subject to a financing condition.

The Merger Agreement provides that the Company or Parent may terminate the Merger Agreement under certain conditions, and in certain specified circumstances, upon termination of the Merger Agreement, the Company will be required to pay Parent a termination fee of $115.9 million or Parent will be required to pay the Company a termination fee of $239.7

million.

We expect the Merger to close during the second half of calendar year 2022.

4.Revenue from Contracts with Customers

We derive revenue from contracts with customers primarily from contracts with the U.S. government in the areas of defense, intelligence, homeland security and other federal civilian agencies. Substantially all of our revenue is derived from services and solutions provided to the U.S. government or to prime contractors supporting the U.S. government, including services by our employees and our subcontractors, and solutions that include third-party hardware and software that we purchase and integrate as a part of our overall solutions. Customer requirements may vary from period-to-period depending on specific contract and customer requirements. We provide our services and solutions under three types of contracts: cost-reimbursable, fixed-price and time-and-materials. Under cost-reimbursable contracts, we are reimbursed for costs that are determined to be reasonable, allowable and allocable to the contract and paid a fee representing the profit margin negotiated between us and the contracting agency, which may be fixed or performance based. Under fixed-price contracts, we perform specific tasks for a fixed price. Fixed-price contracts may include either a product delivery or specific service performance over a defined period. Under time-and-materials contracts, we are reimbursed for labor at fixed hourly rates and are generally reimbursed separately for allowable materials and expenses at cost.

For contracts that do not meet the criteria to measure performance as a right to invoice under the series guidance, we utilize an Estimate at Completion process to measure progress toward completion. We typically estimate progress towards completion based on cost incurred or direct labor incurred. As part of this process, we review information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenue and costs. The risks and opportunities include judgments about the ability and cost to achieve the contract milestones and other technical contract requirements. We make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation, execution by our subcontractors, the availability and timing of funding from our customer and overhead cost rates, among other variables. A significant change in one or more of these estimates could affect the timing in which we recognize revenue on our contracts. For the three months ended ~~March 31,~~June 30, 2022, the aggregate impact of adjustments in contract estimates decreased our revenue by ~~$0.1~~$1.5 million. For the three months ended ~~March 31,~~June 30, 2021, the aggregate impact of adjustments in contract estimates increased our revenue by ~~$2.5~~$5.7 million. For the six months ended June 30, 2022, the aggregate impact of adjustments in contract estimates decreased our revenue by $1.9 million. For the six months ended June 30, 2021, the aggregate impact of adjustments in contract estimates increased our revenue by $6.7 million.

We have 1 reportable segment. Our U.S. government customers typically exercise independent decision-making and contracting authority. Offices or divisions within an agency or department of the U.S. government may directly, or through a prime contractor, use our services as a separate customer as long as the customer has independent decision-making and contracting authority within its organization. We treat sales to U.S. government customers as sales within the U.S. regardless of where the services are performed. WeFor the three months ended and six months ended June 30, 2022 and 2021, we generated ~~nearly~~ 100% of our revenue from sales in the U.S. ~~for each of the three months ended March 31, 2022 and 2021.~~

The following tables disclose revenue (in thousands) by contract type, customer and contractor type for the periods presented.


		Three months ended March 31,					Three months ended June 30,				Six months ended June 30,
		2022		2021			2022		2021		2022		2021
Cost-reimbursable	Cost-reimbursable	$	465,977	$	419,775	Cost-reimbursable	$	476,812	$	443,950	$	942,789	$	863,725
Fixed-price						Fixed-price	100,540		117,474		216,284		249,682
Time-and-materials	Time-and-materials	115,744		81,241		Time-and-materials	92,000		87,154		185,824		168,395
Fixed-price		93,824		132,208
Revenue	Revenue	$	675,545	$	633,224	Revenue	$	669,352	$	648,578	$	1,344,897	$	1,281,802

Three months ended
March 31,
2022 2021
U.S. Government $ 668,408 $ 628,498
State agencies, international agencies and commercial entities 7,137 4,726
Revenue $ 675,545 $ 633,224


	Three months ended June 30,				Six months ended June 30,
	2022		2021		2022		2021
U.S. Government	$	665,773	$	642,755	$	1,338,486	$	1,271,253
State agencies, international agencies and commercial entities	3,579		5,823		6,411		10,549
Revenue	$	669,352	$	648,578	$	1,344,897	$	1,281,802


		Three months ended March 31,					Three months ended June 30,				Six months ended June 30,
		2022		2021			2022		2021		2022		2021
Prime contractor	Prime contractor	$	623,192	$	589,074	Prime contractor	$	622,597	$	602,306	$	1,245,789	$	1,191,380
Subcontractor	Subcontractor	52,353		44,150		Subcontractor	46,755		46,272		99,108		90,422
Revenue	Revenue	$	675,545	$	633,224	Revenue	$	669,352	$	648,578	$	1,344,897	$	1,281,802

The components of our receivables are as follows (in thousands):


		March 31, 2022		December 31, 2021			June 30, 2022		December 31, 2021
Billed receivables	Billed receivables	$	352,496	$	370,115	Billed receivables	$	364,278	$	370,115
Unbilled receivables	Unbilled receivables	130,842		118,387		Unbilled receivables	157,557		118,387
Allowance for doubtful accounts	Allowance for doubtful accounts	(12,232)		(12,467)		Allowance for doubtful accounts	(10,354)		(12,467)
Receivables—net	Receivables—net	$	471,106	$	476,035	Receivables—net	$	511,481	$	476,035

Receivables at ~~March 31,~~June 30, 2022 are expected to be substantially collected within one year except for approximately ~~$7.4~~$8.2 million, of which ~~97%~~100% is related to U.S. government receivables. We do not believe that we have significant exposure to credit risk as billed receivables and unbilled receivables are primarily due from the U.S. government. The allowance for doubtful accounts represents our estimate for exposure due to compliance, contractual issues and bad debts related to prime contractors.

At ~~March 31,~~June 30, 2022 and December 31, 2021, our contract liabilities ~~are $30.3~~were $34.6 million and $36.2 million, respectively. Changes in the balance of contract liabilities are primarily due to the timing difference between our performance and our customers' payments. For the three months ended ~~March 31,~~June 30, 2022, the amount of revenue that was included in the opening contract liabilities balance was ~~$19.7~~$3.4 million. For the six months ended June 30, 2022, the amount of revenue that was included in the opening contract liabilities balance was $23.1 million.

The remaining performance obligation as of ~~March 31,~~June 30, 2022 is ~~$2.2~~$2.3 billion. The following table discloses when we expect to recognize the remaining performance obligation as revenue (in billions):


For the remaining nine months ending December 31, 2022		For the year ending
		December 31, 2023		December 31, 2024		Thereafter
For the remaining six months ending December 31, 2022								For the remaining six months ending December 31, 2022	For the year ending
									December 31, 2023		December 31, 2024		Thereafter
$	1.3	$	0.4	$	0.3	$	0.2	1.0	$	0.6	$	0.3	$	0.4

4.5.Acquisitions

Technical and Management Assistance Corporation (TMAC)—On December 30, 2021, we completed the acquisition of TMAC through a share purchase agreement by and among ManTech International Corporation, Technical and Management Assistance Corporation, Project Cipher, Inc, and its Shareholder. TMAC is a leading provider of advanced data engineering services and solutions that ensure the delivery of vital information to the U.S. Intelligence Community.

The acquisition was accounted for as a business combination. The results of TMAC's operations have been included in our consolidated financial statements since that date. We funded the acquisition with cash on hand.

The ~~preliminary~~ purchase price was $30.3 million, which includes ~~an estimated~~the finalized working capital adjustment. The ~~preliminary~~ purchase price was preliminarily allocated to the underlying assets and liabilities based on their estimated fair value at the date of acquisition. The

excess of the purchase price over the fair value of assets acquired and liabilities assumed was recorded as goodwill. As we are still in the process of reviewing the fair value of the assets acquired and liabilities assumed, the purchase price allocation for TMAC is not complete as of ~~March 31,~~June 30, 2022. In accordance with ASC 805, Business Combinations, we expect to finalize our purchase price allocation within one year of the acquisition date.

Recognition of goodwill is largely attributed to the value paid for TMAC's capabilities, which will broaden our footprint within the U.S. Intelligence Community. The goodwill recorded for this transaction is valued at ~~$14.8~~$15.0 million and will be deductible for tax purposes over 15 years. The components of other intangible assets associated with the acquisition were customer relationships and backlog valued at $15.0 million and $0.7 million, respectively. The fair values of the customer relationships and backlog were determined using the excess earnings method (income approach) in which the value is derived from an estimation of the after-tax cash flows specifically attributable to backlog and customer relationships. Assumptions used in the analysis included revenue and expense forecasts, contributory asset charges, tax amortization benefit and discount rates. Customer contracts and related relationships represent the underlying relationships and agreements with TMAC's existing customers. Customer relationships are amortized using the pattern of benefits method over their estimated useful lives of approximately 20 years. Backlog is amortized using the pattern of benefits method over its estimated useful life of 1 year. The weighted-average amortization period of other intangibles is 19 years.

Gryphon Technologies, Inc. (Gryphon)—On December 9, 2021, we completed the acquisition of Gryphon through a unit purchase agreement by and among ManTech International Corporation, Gryphon Parent, LLC and Gryphon Finance, LLC. Gryphon will further strengthen our long-term competitive position by adding differentiated digital and systems engineering capabilities across the Department of Defense.

The acquisition was accounted for as a business combination. The results of Gryphon's operations have been included in our consolidated financial statements since that date. We funded the acquisition with cash on hand and borrowing under our credit facilities.

The preliminary purchase price was ~~$355.8~~$358.9 million, which includes an estimated working capital adjustment. The preliminary purchase price was preliminarily allocated to the underlying assets and liabilities based on their estimated fair value at the date of acquisition. The excess of the purchase price over the fair value of assets acquired and liabilities assumed was recorded as goodwill. As we are still in the process of reviewing the fair value of the assets acquired and liabilities assumed, the purchase price allocation for Gryphon is not complete as of ~~March 31,~~June 30, 2022. In accordance with ASC 805, Business Combinations, we expect to finalize our purchase price allocation within one year of the acquisition date.

Recognition of goodwill is largely attributed to the value paid for Gryphon's capabilities, which will broaden our footprint within the Department of Defense. Pre-existing goodwill recorded for this transaction will be deductible for tax purposes over 13 years. The remainder of goodwill attributable to the acquisition of Gryphon will not be deductible for tax purposes.

The components of other intangible assets associated with the acquisition were customer relationships and backlog valued at $60.7 million and $5.0 million, respectively. The fair values of the customer relationships and backlog were determined using the excess earnings method (income approach) in which the value is derived from an estimation of the after-tax cash flows specifically attributable to backlog and customer relationships. Assumptions used in the analysis included revenue and expense forecasts, contributory asset charges, tax amortization benefit and discount rates. Customer contracts and related relationships represent the underlying relationships and agreements with Gryphon's existing customers. Customer relationships are amortized using the pattern of benefits method over their estimated useful lives of approximately 20 years. Backlog is amortized using the pattern of benefits method over its estimated useful life of 2 years. The weighted-average amortization period of other intangibles is 19 years.

1011

The following table represents the preliminary purchase price allocation for Gryphon (in thousands):


Cash and cash equivalents	$	20,184
Receivables	~~56,151~~58,554
Prepaid expenses	1,939
Taxes receivable - current	1,418
Other current assets	2,912
Goodwill	~~256,346~~257,928
Other intangible assets	69,067
Property and equipment	2,736
Operating lease right of use assets	5,479
~~Property and equipment~~	~~2,736~~
Other assets	352
Accounts payable	~~(12,221)~~(12,471)
Accrued salaries and related expenses	(20,411)
Contract liabilities	(4,773)
Operating lease obligations—current	(1,243)
Accrued expenses and other current liabilities	~~(1,372)~~(5,153)
Deferred income taxes	~~(13,568)~~(13,361)
Operating lease obligations—long term	(4,287)
Net assets acquired and liabilities assumed	$	~~355,797~~358,870

For the three months ended ~~March 31,~~June 30, 2022, we incurred no acquisition costs related to the Gryphon transactions. For the six months ended June 30, 2022, we incurred approximately $0.1 million of acquisition costs related to the Gryphon transaction, which are included in general and administrative expenses in our consolidated statement of income.

5.6.Earnings Per Share

Under ASC 260, Earnings per Share, the two-class method is an earnings allocation formula that determines earnings per share for each class of common stock according to dividends declared (or accumulated) and participation rights in undistributed earnings. Under that method, basic and diluted earnings per share data are presented for each class of common stock.

In applying the two-class method, we determined that undistributed earnings should be allocated equally on a per share basis between Class A and Class B common stock. Under our Certificate of Incorporation, the holders of the common stock are entitled to participate ratably, on a share-for-share basis as if all shares of common stock were of a single class, in such dividends as may be declared by the Board of Directors. During the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, we declared and paid quarterly dividends in the amounts of $0.41 per share and $0.38 per share, respectively, on both classes of common stock.

Basic earnings per share has been computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during each period. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period in which the shares were outstanding. Diluted earnings per share have been computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares that were outstanding during each period.

1112

The net income available to common stockholders and weighted average number of common shares outstanding used to compute basic and diluted earnings per share for each class of common stock are as follows (in thousands, except per share amounts):


		Three months ended March 31,					Three months ended June 30,				Six months ended June 30,
		2022		2021			2022		2021		2022		2021
Distributed earnings	Distributed earnings	$	16,751	$	15,396	Distributed earnings	$	16,795	$	15,455	$	33,546	$	30,851
Undistributed earnings	Undistributed earnings	14,590		16,932		Undistributed earnings	6,042		21,154		20,632		38,086
Net income	Net income	$	31,341	$	32,328	Net income	$	22,837	$	36,609	$	54,178	$	68,937

Class A common stock:	Class A common stock:					Class A common stock:
Basic net income available to common stockholders	Basic net income available to common stockholders	$	21,617	$	21,809	Basic net income available to common stockholders	$	21,948	$	24,730	$	44,771	$	46,537
Basic weighted average common shares outstanding	Basic weighted average common shares outstanding	28,150		27,317		Basic weighted average common shares outstanding	39,344		27,434		33,778		27,376
Basic earnings per share	Basic earnings per share	$	0.77	$	0.80	Basic earnings per share	$	0.56	$	0.90	$	1.33	$	1.70

Diluted net income available to common stockholders	Diluted net income available to common stockholders	$	21,682	$	21,912	Diluted net income available to common stockholders	$	21,954	$	24,830	$	44,834	$	46,741
Effect of potential exercise of stock options	Effect of potential exercise of stock options	273		401		Effect of potential exercise of stock options	277		345		275		373
Diluted weighted average common shares outstanding	Diluted weighted average common shares outstanding	28,423		27,718		Diluted weighted average common shares outstanding	39,621		27,779		34,053		27,749
Diluted earnings per share	Diluted earnings per share	$	0.76	$	0.79	Diluted earnings per share	$	0.55	$	0.89	$	1.32	$	1.68

Class B common stock:	Class B common stock:					Class B common stock:
Basic net income available to common stockholders	Basic net income available to common stockholders	$	9,724	$	10,519	Basic net income available to common stockholders	$	889	$	11,879	$	9,407	$	22,400
Basic weighted average common shares outstanding	Basic weighted average common shares outstanding	12,662		13,177		Basic weighted average common shares outstanding	1,593		13,177		7,097		13,177
Basic earnings per share	Basic earnings per share	$	0.77	$	0.80	Basic earnings per share	$	0.56	$	0.90	$	1.33	$	1.70

Diluted net income available to common stockholders	Diluted net income available to common stockholders	$	9,659	$	10,416	Diluted net income available to common stockholders	$	883	$	11,779	$	9,344	$	22,196
Diluted weighted average common shares outstanding	Diluted weighted average common shares outstanding	12,662		13,177		Diluted weighted average common shares outstanding	1,593		13,177		7,097		13,177
Diluted earnings per share	Diluted earnings per share	$	0.76	$	0.79	Diluted earnings per share	$	0.55	$	0.89	$	1.32	$	1.68

For the three months ended ~~March 31,~~June 30, 2022 and 2021, options to purchase ~~21,074~~1,505 shares and ~~394~~428 shares, respectively, were outstanding but not included in the computation of diluted earnings per share because the options' effect would have been anti-dilutive. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, options to purchase 11,235 shares and 411 shares, respectively, were outstanding but not included in the computation of diluted earnings per share because the options' effect would have been anti-dilutive. For the six months ended June 30, 2022 and 2021, there were ~~80,429~~99,286 shares and ~~61,804~~125,534 shares, respectively, issued from the exercise of stock options. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021 there were ~~114,659~~139,082 shares and ~~92,295~~117,129 shares, respectively, issued from the vesting of restricted stock units.

6.7.Property and Equipment

Major classes of property and equipment are summarized as follows (in thousands):


		March 31, 2022		December 31, 2021			June 30, 2022		December 31, 2021
Furniture and equipment	Furniture and equipment	$	240,249	$	234,169	Furniture and equipment	$	248,513	$	234,169
Leasehold improvements	Leasehold improvements	78,985		70,932		Leasehold improvements	76,361		70,932
Finance leases	Finance leases	797		797		Finance leases	797		797
Property and equipment—gross	Property and equipment—gross	320,031		305,898		Property and equipment—gross	325,671		305,898
Accumulated depreciation and amortization	Accumulated depreciation and amortization	(183,927)		(172,601)		Accumulated depreciation and amortization	(192,693)		(172,601)
Property and equipment—net	Property and equipment—net	$	136,104	$	133,297	Property and equipment—net	$	132,978	$	133,297

Depreciation and amortization expense related to property and equipment for the three months ended ~~March 31,~~June 30, 2022 and 2021 was ~~$12.8~~$10.7 million and ~~$11.5~~$11.7 million, respectively.

Depreciation and amortization expense related to property and equipment for the six months ended June 30, 2022 and 2021 was $23.5 million and $23.2 million, respectively.

7.8.Goodwill and Other Intangible Assets

The change in the carrying amount of goodwill during the year ended December 31, 2021 and ~~three~~six months ended ~~March 31,~~June 30, 2022 are as follows (in thousands):


	Goodwill Balance
Goodwill at December 31, 2020	$	1,237,894
Acquisitions	260,863
Acquisition fair value adjustment	231
Goodwill at December 31, 2021	1,498,988
Acquisition fair value adjustment	~~10,271~~12,080
Goodwill at ~~March 31,~~June 30, 2022	$	~~1,509,259~~1,511,068

Other intangible assets consisted of the following (in thousands):


		March 31, 2022						December 31, 2021							June 30, 2022						December 31, 2021
		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount			Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Other intangible assets:	Other intangible assets:													Other intangible assets:
Contract and program intangible assets	Contract and program intangible assets	$	512,032	$	269,051	$	242,981	$	517,932	$	262,105	$	255,827	Contract and program intangible assets	$	512,032	$	276,013	$	236,019	$	517,932	$	262,105	$	255,827
Capitalized software	Capitalized software	57,915		48,552		9,363		56,938		47,210		9,728		Capitalized software	58,264		49,945		8,319		56,938		47,210		9,728
Total other intangible assets—net	Total other intangible assets—net	$	569,947	$	317,603	$	252,344	$	574,870	$	309,315	$	265,555	Total other intangible assets—net	$	570,296	$	325,958	$	244,338	$	574,870	$	309,315	$	265,555

Amortization expense relating to intangible assets for the three months ended ~~March 31,~~June 30, 2022 and 2021 was $8.3 million and ~~$6.8~~$6.3 million, respectively. Amortization expense relating to the intangible assets for the six months ended June 30, 2022 and 2021 was $16.6 million and $13.1 million, respectively. Amortization expense for the ~~three~~six months ended ~~March 31,~~June 30, 2021 includes an impairment of $0.3 million for capitalized software. We estimate that we will have the following amortization expense for the future periods indicated below (in thousands):


For the remaining ~~nine~~six months ending December 31, 2022	$	~~23,985~~16,279
For the year ending:
December 31, 2023	$	~~25,548~~26,438
December 31, 2024	$	~~23,182~~23,885
December 31, 2025	$	~~20,549~~20,801
December 31, 2026	$	~~19,340~~19,341
December 31, 2027	$	18,312

8.9.Debt

On July 20, 2021, we amended and restated our credit agreement (Third Amended and Restated Credit Agreement) with a syndicate of lenders led by Bank of America, N.A., as sole administrative agent. The Third Amended and Restated Credit Agreement includes an aggregate principal amount of up to $1.1 billion made available through (i) a $500 million revolving credit facility with a $100 million letter of credit sublimit and a $50 million swing line loan sublimit and (ii) a $600 million delayed-draw term loan facility. Under the delayed-draw term loan facility, borrowings are available to be drawn prior to the first anniversary of the Third Amended and Restated Credit Agreement in up to three separate drawings in a minimal amount of $50 million. The Third Amended and Restated Credit Agreement also includes an accordion feature that permits us to arrange

with the lenders for the provision of additional commitments. The maturity date of the Third Amended and Restated Credit Agreement is July 20, 2026.

Borrowings under the Third Amended and Restated Credit Agreement are collateralized by substantially all of our assets

and those of our Material Subsidiaries and bear interest at one of the following variable rates as selected by us at the time of borrowing: a London Interbank Offer Rate base rate plus market-rate spreads (1.25% to 2.00% based on our consolidated total leverage ratio) or Bank of America's base rate plus market spreads (0.25% to 1.00% based on our consolidated total leverage ratio).

The terms of the Third Amended and Restated Credit Agreement permit prepayment and termination of the loan commitments at any time, subject to certain conditions. The Third Amended and Restated Credit Agreement requires us to comply with specified financial covenants, including the maintenance of certain leverage ratios and a consolidated coverage ratio. The Third Amended and Restated Credit Agreement also contains various covenants, including affirmative covenants with respect to certain reporting requirements and maintaining certain business activities, and negative covenants that, among other things, may limit or impose restrictions on our ability to incur liens, incur additional indebtedness, make investments, make acquisitions and undertake certain other actions. As of and during the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, we were in compliance with these covenants.

There was $300.0 million outstanding on our credit facilities at both ~~March 31,~~June 30, 2022 and December 31, 2021. The maximum available borrowing under the credit facilities at ~~March 31,~~June 30, 2022 was ~~$796.6~~$797.0 million. As of ~~March 31,~~June 30, 2022, we were contingently liable under letters of credit totaling ~~$3.4~~$3.0 million, which reduces our availability to borrow under our credit facilities.

9.10.Commitments and Contingencies

Contracts with the U.S. government, including subcontracts, are subject to extensive legal and regulatory requirements and, from time-to-time, agencies of the U.S. government, in the ordinary course of business, investigate whether our operations are conducted in accordance with these requirements and the terms of the relevant contracts. U.S. government investigations of us, whether related to our U.S. government contracts or conducted for other reasons, could result in administrative, civil or criminal liabilities, including repayments, fines or penalties being imposed upon us, or could lead to suspension or debarment from future U.S. government contracting activities. Management believes it has adequately reserved for any losses that may be experienced from any investigation of which it is aware. The Defense Contract Audit Agency has completed a majority of our incurred cost audits through 2019 with no material adjustments. The remaining audits through 2021 are not expected to have a material effect on our financial position, results of operations or cash flow and management believes it has adequately reserved for any losses.

In the normal course of business, we are involved in certain governmental and legal proceedings, claims and disputes and have litigation pending under several suits. We believe that the ultimate resolution of these matters will not have a material effect on our financial position, results of operations or cash flows.

We have ~~$3.4~~$3.0 million outstanding on our letter of credit, of which $1.6 million is related to an outstanding performance bond in connection with a contract between ManTech MENA, LLC and Jadwalean International Operations and Management Company to fulfill technical support requirements for the Royal Saudi Air Force.

~~10.~~11.Stockholders' Equity and Stock-Based Compensation

Common Stock

On March 28, 2022, 11,580,000 shares of Class B common stock were converted to Class A common stock. On ~~March 31,~~June 30, 2022, there were ~~39,350,643~~39,380,498 shares of Class A common stock outstanding, 244,113 shares of Class A common stock as treasury stock, and ~~1,596,695~~1,586,695 shares of Class B common stock outstanding.

Accounting for Stock-Based Compensation

Our 2016 Management Incentive Plan (the Plan) was designed to attract, retain and motivate key employees. The types of awards available under the Plan include, among others, stock options, restricted stock and restricted stock units (RSUs). Equity awards granted under the Plan are settled in shares of Class A common stock. At the beginning of each year, the Plan provides that the number of shares available for issuance automatically increases by an amount equal to 1.5% of the total number of shares of Class A and Class B common stock outstanding on December 31st of the previous year. On January 2, 2022, there were 611,934 additional shares made available for issuance under the Plan. Through ~~March 31,~~June 30, 2022, the Board of Directors has

authorized the issuance of up to 16,970,005 shares under this Plan. Through ~~March 31,~~June 30, 2022, the remaining aggregate number of shares of our common stock available for future grants under the Plan was ~~8,213,337.~~8,214,622. The Plan expires in March 2026.

The Plan is administered by the compensation committee of our Board of Directors, along with its delegates. Subject to the express provisions of the Plan, the committee has the Board of Directors’ authority to administer and interpret the Plan, including the discretion to determine the exercise price, vesting schedule, contractual life and the number of shares to be issued.

Stock Compensation Expense—For the three months ended ~~March 31,~~June 30, 2022 and 2021, we recorded ~~$3.9~~$4.4 million and ~~$3.4~~$4.2 million, respectively, of stock-based compensation expense. For the six months ended June 30, 2022 and 2021, we recorded $8.3 million and $7.6 million, respectively, of stock-based compensation expense. No compensation expense of employees with stock awards, including stock-based compensation expense, was capitalized during the periods. For the three months ended ~~March 31,~~June 30, 2022 and 2021, we recorded ~~$0.9~~$0.1 million and $0.5 million, respectively, to income tax benefit related to the exercise of stock options, vested cancellations and the vesting of restricted stock and restricted stock units. For the six months ended June 30, 2022 and 2021, we recorded $1.0 million and $1.5 million, respectively, to income tax benefit related to the exercise of stock options, vested cancellations and the vesting of restricted stock and restricted stock units.

Stock Options—Under the Plan, we have issued stock options in the past. A stock option gives the holder the right, but not the obligation to purchase a certain number of shares at a predetermined price for a specific period of time. We did not grant any options during the ~~three~~six months ended ~~March 31,~~June 30, 2022 and year ended December 31, 2021.

We have used the Black-Scholes-Merton option pricing model to determine the fair value of our awards on the date of grant. We will reconsider the use of the Black-Scholes-Merton model if additional information becomes available in the future that indicates another model would be more appropriate or if grants issued in future periods have characteristics that cannot be reasonably estimated under this model. Option grants that vested during the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021 had a combined fair value of $0.6 million and $1.1 million, respectively.

The following table summarizes stock option activity for the year ended December 31, 2021 and the ~~three~~six months ended ~~March 31,~~June 30, 2022:


		Number of Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value (in thousands)		Weighted Average Remaining Contractual Life		Number of Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value (in thousands)		Weighted Average Remaining Contractual Life
Stock options outstanding at December 31, 2020	Stock options outstanding at December 31, 2020	785,827	$	56.33	$	25,629		Stock options outstanding at December 31, 2020	785,827	$	56.33	$	25,629
Exercised	Exercised	(196,735)	$	48.65	$	7,168		Exercised	(196,735)	$	48.65	$	7,168
Cancelled and expired	Cancelled and expired	(21,776)	$	63.80				Cancelled and expired	(21,776)	$	63.80
Stock options outstanding at December 31, 2021	Stock options outstanding at December 31, 2021	567,316	$	58.70	$	8,380		Stock options outstanding at December 31, 2021	567,316	$	58.70	$	8,380
Exercised	Exercised	(80,429)	$	50.66	$	2,360		Exercised	(99,286)	$	52.15	$	3,253
Cancelled and expired	Cancelled and expired	(8,399)	$	62.50				Cancelled and expired	(9,983)	$	64.05
Stock options outstanding at March 31, 2022		478,488	$	59.99	$	12,538	2 years
Stock options outstanding at June 30, 2022								Stock options outstanding at June 30, 2022	458,047	$	60.01	$	16,235	2 years

Stock options exercisable at March 31, 2022		422,687	$	58.03	$	11,905	2 years
Stock options exercisable at June 30, 2022								Stock options exercisable at June 30, 2022	403,471	$	58.00	$	15,112	1 year

The following table summarizes non-vested stock options for the ~~three~~six months ended ~~March 31,~~June 30, 2022:


		Number of Shares	Weighted Average Fair Value			Number of Shares	Weighted Average Fair Value
Non-vested stock options at December 31, 2021	Non-vested stock options at December 31, 2021	114,067	$	12.16	Non-vested stock options at December 31, 2021	114,067	$	12.16
Vested	Vested	(54,825)	$	10.04	Vested	(55,167)	$	10.07
Cancelled	Cancelled	(3,441)	$	12.17	Cancelled	(4,324)	$	12.59
Non-vested stock options at March 31, 2022		55,801	$	14.23
Non-vested stock options at June 30, 2022					Non-vested stock options at June 30, 2022	54,576	$	14.23

Unrecognized compensation expense related to non-vested awards was ~~$0.5~~$0.3 million as of ~~March 31,~~June 30, 2022, which is expected to be recognized over a weighted-average period of ~~1 year.~~0.3 years.

Restricted Stock—Under the Plan, we have issued restricted stock. A restricted stock award is an issuance of shares that cannot be sold or transferred by the recipient until the vesting period lapses. Restricted stock issued to members of our Board of Directors vest on the one year anniversary of the grant date. The related compensation expense is recognized over the service period and is based on the grant date fair value of the stock. The grant date fair value of the restricted stock is equal to

the closing market price of our common stock on the date of grant.

~~There was no activity for the three months ended March 31, 2022.~~ The following table summarizes the restricted stock activity during the year ended December 31, ~~2021:~~2021 and the six months ended June 30, 2022:


		Number of Shares	Weighted Average Fair Value			Number of Shares	Weighted Average Fair Value
Non-vested restricted stock at December 31, 2020	Non-vested restricted stock at December 31, 2020	24,000	$	71.11	Non-vested restricted stock at December 31, 2020	24,000	$	71.11
Granted	Granted	24,000	$	86.01	Granted	24,000	$	86.01
Vested	Vested	(24,000)	$	71.11	Vested	(24,000)	$	71.11
Non-vested restricted stock at December 31, 2021	Non-vested restricted stock at December 31, 2021	24,000	$	86.01	Non-vested restricted stock at December 31, 2021	24,000	$	86.01
Vested					Vested	(24,000)	$	86.01
Non-vested restricted stock at June 30, 2022					Non-vested restricted stock at June 30, 2022	—	$	—

RSUs—Under the Plan, we have issued restricted stock units (RSUs). RSUs are not actual shares, but rather a right to receive shares in the future. The shares are not issued and the employee cannot sell or transfer shares prior to vesting and have no voting rights until the RSUs vest. Employees who are granted RSUs do not receive dividend payments during the vesting period. Our employees' time-based RSUs generally provide for the delivery of shares in one-third increments on the first, second and third anniversaries of the date of grant. The grant date fair value of the RSUs is equal to the closing market price of our common stock on the grant date less the present value of dividends expected to be awarded during the service period. We recognize the grant date fair value of RSUs of shares we expect to issue as compensation expense ratably over the requisite service period.

The following table summarizes the non-vested RSU activity during the year ended December 31, 2021 and the ~~three~~six months ended ~~March 31,~~June 30, 2022:


		Number of Units	Weighted Average Fair Value			Number of Units	Weighted Average Fair Value
Non-vested RSUs at December 31, 2020	Non-vested RSUs at December 31, 2020	346,799	$	64.48	Non-vested RSUs at December 31, 2020	346,799	$	64.48
Granted	Granted	236,240	$	78.78	Granted	236,240	$	78.78
Vested	Vested	(152,121)	$	61.06	Vested	(152,121)	$	61.06
Forfeited	Forfeited	(25,564)	$	67.07	Forfeited	(25,564)	$	67.07
Non-vested RSUs at December 31, 2021	Non-vested RSUs at December 31, 2021	405,354	$	73.94	Non-vested RSUs at December 31, 2021	405,354	$	73.94
Granted	Granted	199,100	$	81.02	Granted	200,760	$	81.02
Vested	Vested	(114,959)	$	71.01	Vested	(116,422)	$	71.09
Forfeited	Forfeited	(16,694)	$	74.55	Forfeited	(24,622)	$	75.30
Non-vested RSUs at March 31, 2022		472,801	$	77.61
Non-vested RSUs at June 30, 2022					Non-vested RSUs at June 30, 2022	465,070	$	77.64

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Statements

All statements and assumptions contained in this Quarterly Report on Form 10-Q that do not relate to historical facts constitute "forward-looking statements." These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often include the use of words such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate," "plan" and words and terms of similar substance in connection with discussions of future events, situations or financial performance. While these statements represent our current expectations, no assurance can be given that the results or events described in such statements will be achieved.

Forward-looking statements may include, among other things, statements with respect to our financial condition, results of operations, prospects, business strategies, competitive position, growth opportunities, and plans and objectives of management. Such statements are subject to numerous assumptions, risks, uncertainties and other factors, many of which are outside of our control, and include, without limitations, the risks and uncertainties discussed in ~~the~~ Item 1A "Risk Factors" in Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2021.~~2021 and in Item 1A "Risk Factors" in Part II of this Form 10-Q.

Factors or risks that could cause our actual results to differ materially from the results we anticipate include, but are not limited to, the following:

•failure to maintain our relationship with the U.S. government, or the failure to win new contract awards or to retain existing U.S. government contracts;

•inability to recruit and retain a sufficient number of employees with specialized skill sets or necessary security clearances who are in great demand and limited supply;

•adverse changes in U.S. government spending for programs we support, whether due to changing mission priorities, socio-economic policies or federal budget constraints generally;

•disruptions to our business resulting from the COVID-19 pandemic or other similar global health epidemics, pandemics and/or other disease outbreaks;

•failure to compete effectively for awards procured through the competitive bidding process, and the adverse impact of delays resulting from our competitors' protests of new contracts that are awarded to us;

•disruptions to our business or damage to our reputation resulting from cyber attacks and other security threats;

•failure to obtain option awards, task orders or funding under our contracts;

•the government renegotiating, modifying or terminating our contracts;

•failure to comply with, or adverse changes in, complex U.S. government laws and procurement regulations;

•adverse results of U.S. government audits or other investigations of our government contracts;

•failure to successfully integrate acquired companies or businesses into our operations or to realize any accretive or synergistic effects from such acquisitions;

•failure to mitigate risks associated with conducting business internationally; ~~and~~

•adverse changes in business conditions that may cause our investments in recorded goodwill to become ~~impaired.~~impaired;

•the conditions to the closing of the proposed Merger may not be satisfied or waived, and the proposed Merger may not be consummated within the expected time period or at all;

•our business may suffer as a result of uncertainty surrounding the Merger, and the proposed Merger may disrupt our current plans and operations or divert management’s attention from ongoing business operations;

•difficulties with our ability to retain and hire key personnel and maintain our business relationships as a result of the proposed Merger may occur;

•we have incurred and expect to continue to incur significant costs in connection with the Merger, some of which are payable by us regardless of whether the Merger is completed;

•the occurrence of certain events, changes or other circumstances could, under the terms of the Merger Agreement, give rise to termination of the Merger Agreement;

•stockholder litigation in connection with the Merger could affect the timing or occurrence of the Merger and could result in significant costs; and

•if the Merger is completed, stockholders will forego realization of any long-term value potential based on current strategy as an independent public company.

We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to update any forward-looking statement made herein following the date of this Quarterly Report, whether as a result of new information, subsequent events or circumstances, changes in expectations or otherwise.

Overview

We provide mission-focused technology solutions and services for U.S. defense, intelligence community and federal civilian agencies. We excel in full-spectrum cyber, secure mission & enterprise IT, advanced data analytics, software and systems development, intelligent systems engineering, intelligence mission support and mission operations.

Approximately 99% of our revenue is generated through contracts with the U.S. federal government, or through prime contractors supporting the U.S. government. The U.S. government is the largest consumer of services and solutions in the U.S. As such, our business is impacted by the overall U.S. government budget and our ability to match our capabilities and offerings to the U.S. government's spending priorities. On March 15, 2022, the President signed the omnibus spending bill funding the government for the remainder of Government Fiscal Year (GFY) 2022. The GFY 2022 budget includes $729 billion for national defense programs. The President’s GFY 2023 budget proposal includes $773 billion for national defense, a 4% increase over GFY 2022 amounts.

We are continuing to monitor impacts of the global outbreak of the COVID-19 pandemic including new variants of the virus, specific impacts and mitigation protocols enacted in regions in which we operate, and the vaccination status of our employees. In preparation of the President's Executive Order requiring all federal employees and contractors supporting the federal government be vaccinated (or to have an approved accommodation) as well as to promote the well-being of our workforce, we have and continue to encourage our employees to get vaccinated. There is currently an injunction suspending the President’s executive order requiring vaccination of our workforce. We cannot predict the potential impact of the

vaccination mandate, if enforced, or the overall evolution of the pandemic and its further impacts on the economy or our business.

The U.S. is currently experiencing the highest inflation in 40 years. In response to the increasing inflation rates, the Federal Reserve has begun, and is signaling the intent to continue through 2022, increasing interest rates. Increasing interest rates will increase the amounts of interest we pay on our outstanding debt.

We recommend that you read this discussion and analysis in conjunction with our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, previously filed with the Securities and Exchange Commission.

17Proposed Merger

On May 13, 2022 the Company entered into the Merger Agreement with Parent and Merger Sub. Pursuant to the Merger Agreement, and in accordance with the terms and subject to the conditions thereof, Merger Sub will merge with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, the Company will be acquired by the Parent, which will be controlled by investment funds managed by The Carlyle Group Inc. The consummation of the Merger is subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Refer to Note 3, Proposed Merger, in the notes to the financial statements in this Form 10-Q.

Three Months Ended ~~March 31,~~June 30, 2022 Compared to the Three Months Ended ~~March 31,~~June 30, 2021

The following table sets forth certain items from our condensed consolidated statements of income and the relative percentage that certain items of expenses and earnings bear to revenue, as well as the period-to-period change from ~~March 31,~~June 30, 2021 to ~~March 31,~~June 30, 2022.


		Three months ended March 31,								Period-to-Period Change					Three months ended June 30,								Period-to-Period Change
		2022		2021		2022		2021		2021 to 2022					2022		2021		2022		2021		2021 to 2022
		Dollars				Percentage				Dollars		Percentage			Dollars				Percentage				Dollars		Percentage
		(dollars in thousands)													(dollars in thousands)
REVENUE	REVENUE	$	675,545	$	633,224	100.0	%	100.0	%	$	42,321	6.7	%	REVENUE	$	669,352	$	648,578	100.0	%	100.0	%	$	20,774	3.2	%
Cost of services	Cost of services	575,971		542,717		85.3	%	85.7	%	33,254		6.1	%	Cost of services	573,373		552,868		85.7	%	85.2	%	20,505		3.7	%
General and administrative expenses	General and administrative expenses	55,736		48,086		8.2	%	7.6	%	7,650		15.9	%	General and administrative expenses	61,054		47,048		9.1	%	7.3	%	14,006		29.8	%
OPERATING INCOME	OPERATING INCOME	43,838		42,421		6.5	%	6.7	%	1,417		3.3	%	OPERATING INCOME	34,925		48,662		5.2	%	7.5	%	(13,737)		(28.2)	%
Interest expense	Interest expense	(2,242)		(354)		0.3	%	0.1	%	1,888		533.3	%	Interest expense	(2,033)		(366)		0.3	%	0.1	%	1,667		455.5	%
Interest income	Interest income	53		40		—	%	—	%	13		32.5	%	Interest income	46		39		—	%	—	%	7		17.9	%
Other income (expense), net		112		(121)		—	%	—	%	233		192.6	%
Other (expense), net														Other (expense), net	(11)		(12)		—	%	—	%	(1)		(8.3)	%
INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	41,761		41,986		6.2	%	6.6	%	(225)		(0.5)	%	INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	32,927		48,323		4.9	%	7.4	%	(15,396)		(31.9)	%
Provision for income taxes	Provision for income taxes	(10,420)		(9,657)		1.6	%	1.5	%	763		7.9	%	Provision for income taxes	(10,090)		(11,714)		1.5	%	1.8	%	(1,624)		(13.9)	%
Equity in losses of unconsolidated subsidiaries		—		(1)		—	%	—	%	(1)		(100.0)	%
NET INCOME	NET INCOME	$	31,341	$	32,328	4.6	%	5.1	%	$	(987)	(3.1)	%	NET INCOME	$	22,837	$	36,609	3.4	%	5.6	%	$	(13,772)	(37.6)	%

Revenue

The primary drivers of our increase in revenue relates to revenue from recent acquisitions, new contract awards and growth on certain existing contracts. This increase was offset by contracts and tasks that ended and reduced scope of work on some contracts, including contracts with variable material purchase requirements.

Cost of services

The increase in cost of services was primarily due to increases in revenue. As a percentage of revenue, direct labor costs were 50% and 49% for the three months ended June 30, 2022 and 2021, respectively. As a percentage of revenue, other direct costs, which include subcontractors and third party equipment and materials used in the performance of our contracts, was 35% and 36% for the three months ended June 30, 2022 and 2021, respectively. Profitability is relatively flat due to lower program profits and higher benefit costs.

General and administrative expenses

The increase in general and administrative expenses was primarily due to additional legal and transaction fees incurred in relation to our Merger Agreement of $6.9 million as well as higher amortization expense associated with intangibles from our recent acquisitions. As a percentage of revenue, general and administrative expenses increased for the three months ended June 30, 2022 as compared to the same period in 2021.

Interest expense

The increase in interest expense was due to interest on borrowing associated with the acquisitions of Gryphon and TMAC.

Provision for income taxes

Our effective tax rate is affected by recurring items, such as the relative amount of income we earn in various taxing jurisdictions and their tax rates. It is also affected by discrete items that may occur in any given year, but are not consistent from year-to-year. Our effective income tax rate was 31% and 24% for the three months ended June 30, 2022 and 2021, respectively. The increase in the effective tax rate is primarily due to market fluctuations in the executive deferred compensation plan, lower stock option exercises when compared to the previous period and limits on the deductibility of transaction fees incurred with our Merger Agreement.

Six Months Ended June 30, 2022 Compared to the Six Months Ended June 30, 2021


	Six months ended June 30,								Period-to-Period Change
	2022		2021		2022		2021		2021 to 2022
	Dollars				Percentage				Dollars		Percentage
	(dollars in thousands)
REVENUE	$	1,344,897	$	1,281,802	100.0	%	100.0	%	$	63,095	4.9	%
Cost of services	1,149,344		1,095,585		85.5	%	85.5	%	53,759		4.9	%
General and administrative expenses	116,790		95,134		8.7	%	7.4	%	21,656		22.8	%
OPERATING INCOME	78,763		91,083		5.8	%	7.1	%	(12,320)		(13.5)	%
Interest expense	(4,275)		(720)		0.3	%	0.1	%	3,555		493.8	%
Interest income	99		79		—	%	—	%	20		25.3	%
Other income (expense), net	101		(133)		—	%	—	%	234		175.9	%
INCOME FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY METHOD INVESTMENTS	74,688		90,309		5.5	%	7.0	%	(15,621)		(17.3)	%
Provision for income taxes	(20,510)		(21,371)		1.5	%	1.6	%	(861)		(4.0)	%
Equity in losses of unconsolidated subsidiaries	—		(1)		—	%	—	%	(1)		(100.0)	%
NET INCOME	$	54,178	$	68,937	4.0	%	5.4	%	$	(14,759)	(21.4)	%

Revenue

The primary drivers of our increase in revenues relates revenue from recent acquisitions, new contract awards and growth on certain existing contracts. This increase was offset by contracts and tasks that ended and reduced scope of work on some contracts, including contracts with variable material purchase requirements. We expect revenue to increase in the remainder of 2022 due to our recent acquisitions as well as new contracts and growth on existing programs.

Cost of services

The increase in cost of services was primarily due to increases in revenue. As a percentage of revenue, direct labor costs were 51% ~~and 52%~~ for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and ~~2021, respectively.~~2021. As a percentage of revenue, other direct costs, which include subcontractors and third party equipment and materials used in the performance of our contracts, was ~~34%~~35% for ~~both~~ the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021. ~~Profitability has increased due to higher program profits including improved award fees as compared to the prior period.~~ We expect cost of services as a percentage of revenue to ~~increase in~~decrease slightly for the remainder of 2022.

General and administrative expenses

The increase in general and administrative expenses was primarily due additional legal and transaction fees incurred in relation to ~~one-time expenses and~~our Merger Agreement of $7.3 million as well as higher amortization expense associated with intangibles from our recent acquisitions. As a percentage of revenue, general and administrative expenses ~~increased~~increase for the ~~three~~six months ended ~~March 31,~~June 30, 2022 as compared to the same period in 2021. Whether successful or not, we expect to incur additional expense in relation to the proposed Merger. We expect ~~general and administrative expenses as a percentage of revenue~~the merger to ~~remain~~be completed in the ~~same or slightly decrease the remainder~~second half of 2022.

Interest expense

The increase in interest expense was due to interest on borrowing associated with the acquisitions of Gryphon and TMAC. We expect interest expense may increase in the short term as interest rates rise, but to decrease later in 2022 as we expect to reduce our outstanding loan balances.

Provision for income taxes

Our effective tax rate is affected by recurring items, such as the relative amount of income we earn in various taxing jurisdictions and their tax rates. It is also affected by discrete items that may occur in any given year, but are not consistent from year-to-year. Our effective income tax rate was ~~25%~~27% and ~~23%~~24% for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, respectively. The increase in the effective tax rate is ~~primarily due to~~ market fluctuations in the executive deferred compensation ~~plan. We expect~~plan, lower stock option exercises when compared to the ~~effective tax rate to remain consistent in~~previous period and limits on the ~~remainder~~deductibility of ~~2022.~~transaction fees incurred with our Merger Agreement.

Backlog

At ~~March 31,~~June 30, 2022 and December 31, 2021, our backlog was ~~$10.3~~$10.4 billion and $10.6 billion, respectively. Our funded backlog was ~~$1.4~~$1.7 billion and $1.6 billion as of ~~March 31,~~June 30, 2022 and December 31, 2021, respectively. Backlog represents estimates that we calculate on a consistent basis. For additional information on how we compute backlog, see the disclosure under the caption "Backlog," contained in "Item 11. Business" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Liquidity and Capital Resources

Our primary sources of liquidity are cash provided by operations and our credit facilities. On ~~March 31,~~June 30, 2022, our cash and cash equivalents balance was ~~$60.3~~$46.8 million. There was $300.0 million outstanding under our credit facilities at ~~March 31,~~June 30, 2022. As of ~~March 31,~~June 30, 2022, we were contingently liable under letters of credit totaling ~~$3.4~~$3.0 million, which reduces our availability to borrow under our credit facilities. The maximum available borrowings under our credit facilities at ~~March 31,~~June 30, 2022 were ~~$796.6~~$797.0 million. These sources of liquidity have met the short-term and long-term liquidity needs for financing of acquisitions, working capital, payment under our cash dividend program and capital expenditures.

Cash provided by operating activities has been adequate to fund our operations, including payments under our regular cash dividend program. When there are short-term fluctuations in our cash flows and level of operations, we may from time-to-time increase borrowings under our credit facilities to meet cash demands.

Cash Flows From (Used In) Operating Activities

Our operating cash flow is primarily affected by our ability to invoice and collect from our customers in a timely manner, our ability to manage our vendor payments and the overall profitability of our contracts. We bill most of our customers monthly after services are rendered. Our accounts receivable days sales outstanding were 6369 and 6164 for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, respectively. Our net cash flow from operating activities was ~~$34.5~~$43.9 million and $66.5 million for the ~~three~~six months ended ~~March 31,~~June 30, 2022 and ~~our net cash used in operating activities was $8.2 million for the three months ended March 31, 2021.~~June 30, 2021, respectively. The ~~increase~~decrease in net cash flow from operating activities over the

comparative period was primarily related to the timing of payments to vendors, an increase in estimated tax payments related to the capitalization of Section 174 expenses, and a decrease in net income, offset by the timing of customer ~~collections and payment of vendors.~~collections. Beginning in 2022, ~~we are required to defer over 5 years~~the Tax Cuts and Jobs Act of 2017 requires expenses that meet the definition under Section 174 of the Internal Revenue ~~Code.~~Code to be deferred over 5 years. Absent a repeal of this provision in the tax code, we expect amounts paid for income taxes to ~~increase during the remainder of 2022~~be increased by approximately $20 ~~million.~~million in 2022.

Cash Flows From (Used In) Investing Activities

Our cash used in investing activities consists primarily of business combinations, purchases of property and equipment and investments in capital software. For the ~~three~~six months ended ~~March 31,~~June 30, 2022 our net cash used in investing activities was ~~$11.2~~$18.4 million, which was due to the purchase of equipment to support managed IT service contracts and infrastructure investment, partially offset by proceeds from our corporate owned life insurance. For the ~~three~~six months ended ~~March 31,~~June 30, 2021 our net cash used in investing activities was ~~$17.9~~$30.9 million, which was due to the purchase of equipment to support managed IT service contracts.

Cash Flows From (Used in) Financing Activities

For the ~~three~~six months ended ~~March 31,~~June 30, 2022, our net cash used in financing activities was ~~$16.4~~$32.1 million, which was primarily due to dividends ~~paid and payment consideration to tax authority on employee's behalf, partially offset by proceeds from the exercise of stock options.~~paid. For the ~~three~~six months ended ~~March 31,~~June 30, 2021, our net cash used in financing activities was ~~$8.2~~$11.9 million, which was primarily the result of our dividend payments, offset by net borrowings under our credit facility.

Credit Facilities

On July 20, 2021, we amended and restated our credit agreement ~~(Third Amended and Restated Credit Agreement)~~ with a syndicate of lenders led by Bank of America, N.A., as sole administrative agent. The Third Amended and Restated Credit Agreement includes an aggregate principal amount of up to $1.1 billion made available through (i) a $500 million revolving credit facility with a $100 million letter of credit sublimit and a $50 million swing line loan sublimit and (ii) a $600 million delayed-draw term loan facility. Under the delayed-draw term loan facility, borrowings are available to be drawn prior to the first anniversary of the Third Amended and Restated Credit Agreement in up to three separate drawings in a minimal amount of $50 million. The Third Amended and Restated Credit Agreement also includes an accordion feature that permits us to arrange with the lenders for the provision of additional commitments. The maturity date of the Third Amended and Restated Credit Agreement is July 20, 2026.

Borrowings under the Third Amended and Restated Credit Agreement are collateralized by substantially all of our assets and those of our Material Subsidiaries and bear interest at one of the following variable rates as selected by us at the time of borrowing: a London Interbank Offer Rate base rate plus market-rate spreads (1.25% to 2.00% based on our consolidated total leverage ratio) or Bank of America's base rate plus market spreads (0.25% to 1.00% based on our consolidated total leverage ratio).

There was $300.0 million outstanding on our credit facilities at ~~March 31,~~June 30, 2022. As of and during the ~~three~~six months ended ~~March 31,~~June 30, 2022, we were in compliance with the covenants under the Third Amended and Restated Credit Agreement.

Capital Resources

We believe the capital resources available to us from cash on hand, our capacity under our credit facilities, and cash from our operations are adequate to fund our anticipated cash requirements for at least the next year. We anticipate financing our internal and external growth through cash from operating activities, borrowings under our credit facilities and issuance of equity.

Cash Management

To the extent possible, we invest our available cash in short-term, investment grade securities in accordance with our investment policy. Under our investment policy, we manage our investments in accordance with the priorities of maintaining the safety of our principal, maintaining the liquidity of our investments, maximizing the yield on our investments and investing our cash to the fullest extent possible. Our investment policy provides that no investment security can have a final maturity that exceeds six months and that the weighted average maturity of the portfolio cannot exceed 60 days. Cash and cash equivalents include cash on hand, amounts due from banks and short-term investments with maturity dates of three months or less at the date of purchase.

Dividend

During the ~~three~~six months ended ~~March 31,~~June 30, 2022 and 2021, we declared and paid a quarterly dividend in the amount of $0.41 per share and $0.38 per share, respectively, on both classes of our common stock. ~~While we expect to continue~~We will not be declaring a dividend in the cash dividend program, any future dividends declared will be at the discretion of our Board of Directors and will depend, among other factors, upon our results of operations, financial condition and cash requirements, as well as such other factors that our Board of Directors deems relevant.third quarter.

Critical Accounting Estimates

The discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The preparation of these condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting estimates are set forth under the caption "Critical Accounting Estimates" in Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, previously filed with the SEC. There have been no material changes to our critical accounting estimates from those discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Recently Adopted Accounting Standards Updates

Accounting Standards Updates that became effective during the ~~three~~six months ended ~~March 31,~~June 30, 2022 did not have a material impact on our condensed consolidated financial statements.

Recently Issued But Not Yet Adopted ASUs

ASUs effective after ~~March 31,~~June 30, 2022 are not expected to have a material effect on our condensed consolidated financial statements.

Item 3.Quantitative and Qualitative Disclosures about Market Risk

Our exposure to market risk relates to changes in interest rates for borrowing under our credit facilities. At ~~March 31,~~June 30, 2022, we had $300.0 million outstanding on our credit facilities. Borrowings under our credit facilities bear interest at variable rates. A hypothetical 10% increase in interest rates would have a ~~$0.5~~$0.6 million effect on our interest expense for the ~~three~~six months ended ~~March 31,~~June 30, 2022.

We do not use derivative financial instruments for speculative or trading purposes. When we have excess cash, we invest in short-term, investment grade, interest-bearing securities. Our investments are made in accordance with an investment policy. Under this policy, no investment securities can have maturities exceeding six months and the weighted average maturity of the portfolio cannot exceed 60 days.

Item 4.Controls and Procedures

Management is responsible for establishing and maintaining adequate disclosure controls and procedures and internal control over financial reporting. Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act, such as this Quarterly Report on Form 10-Q, is accurately recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

It should be noted that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. As a result, our disclosure controls and procedures are designed to provide reasonable assurance that such disclosure controls and procedures will meet their objectives.

As of ~~March 31,~~June 30, 2022, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), management evaluated the effectiveness of

the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level described above.

There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2124

PART II – OTHER INFORMATION

Item 1.Legal Proceedings

We are subject to certain legal proceedings, government audits, investigations, claims and disputes that arise in the ordinary course of our business. Like most large government defense contractors, our contract costs are audited and reviewed on a continual basis by an in-house staff of auditors from the Defense Contract Audit Agency. In addition to these routine audits, we are subject from time-to-time to audits and investigations by other agencies of the U.S. government. These audits and investigations are conducted to determine if our performance and administration of our government contracts are compliant with contractual requirements and applicable federal statutes and regulations. An audit or investigation may result in a finding that our performance, systems and administration are compliant or, alternatively, may result in the government initiating proceedings against us or our employees, including administrative proceedings seeking repayment of monies, suspension and/or debarment from doing business with the U.S. government or a particular agency or civil or criminal proceedings seeking penalties and/or fines. Audits and investigations conducted by the U.S. government frequently span several years.

Although we cannot predict the outcome of these and other legal proceedings, investigations, claims and disputes, based on the information now available to us, we do not believe the ultimate resolution of these matters, either individually or in the aggregate, will have a material adverse effect on our business, prospects, financial condition or operating results.

Item 1A. Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Item 1A “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. There have been no material changes to our risk factors from those set forth in our Annual Report on Form 10-K the fiscal year ended December 31, 2021, except as follows:

Risks Related to the Proposed Merger

Failure to complete the proposed Merger or a delay in completion of the Merger could negatively impact the price of our common stock, as well as our future business and financial results.

On May 13, 2022, we entered into the Merger Agreement, pursuant to which we will be acquired by Parent, which will be controlled by investment funds managed by The Carlyle Group, as described in Note 3, Proposed Merger, in the notes to the financial statements in this Form 10-Q. The consummation of the Merger is subject to the satisfaction or waiver of closing conditions specified in the Merger Agreement, including, among others, (1) the adoption of the Merger Agreement by the Company’s stockholders, (2) the expiration or termination of any waiting period (and any extension thereof) under the HSR Act (which expired on June 20, 2022), (3) the absence of any law or order by a governmental authority that has the effect of preventing, making illegal or prohibiting the consummation of the Merger or any other transaction contemplated by the Merger Agreement and (4) the absence of a “Company Material Adverse Effect” (as defined in the Merger Agreement). We cannot assure you that all of the closing conditions specified in the Merger Agreement will be satisfied or waived on a timely basis. If the conditions to the Merger are not satisfied or waived on a timely basis, we may be unable to complete the Merger as quickly as expected or at all.

If the Merger is not completed, our ongoing business may be adversely affected as follows:

•we may experience negative reactions from the financial markets, including negative impacts on the market price of our common stock;

•some of management's attention will have been directed to the Merger instead of being directed to our day-to-day operations and the pursuit of other opportunities that could have been beneficial to us;

•the manner in which our business partners and other third parties perceive us may be negatively impacted, which in turn could affect our ability to compete for business;

•we may experience negative reactions from our employees;

•we could be subject to litigation related to any failure to complete the Merger or related to any enforcement proceeding commenced against us to perform our obligations under the Merger Agreement;

•we will be required to pay our costs relating to the Merger, whether or not the Merger is completed; and

•we may be required, in certain circumstances, to pay a termination fee of $115.9 million, as provided in the Merger Agreement.

In addition, any significant delay in consummating the Merger could have an adverse effect on our operating results, could adversely affect our relationships with our business partners and would likely lead to a significant diversion of management and employee attention.

Additionally, in approving the Merger Agreement, the Board of Directors considered a number of factors and potential benefits, including the fact that the merger consideration to be received by holders of the Company’s common stock represented a significant premium to the recent market price. If the Merger is not completed, neither the Company nor the holders of our common stock will realize this benefit of the Merger. Moreover, we would also have nevertheless incurred substantial transaction-related costs and the loss of management time and resources.

Uncertainties associated with the Merger may cause a loss of management and other key employees and disrupt our business relationships, which could adversely affect our business.

Uncertainty about the effect of the Merger on our employees and business relationships may have an adverse effect on our business. These uncertainties may impair our ability to attract, retain and motivate key personnel until the Merger is completed and for a period of time thereafter. Employee retention may be particularly challenging during the pendency of the Merger. If key employees depart and as we face additional uncertainties relating to the Merger, our business relationships may be subject to disruption. If key employees depart or if our existing business relationships suffer, our results of operations may be adversely affected. The adverse effects of such disruptions could be further exacerbated by any delay in the completion of the Merger.

We will incur significant costs in connection with the Merger.

We have incurred and expect to continue to incur significant costs in connection with the Merger. These costs include fees paid to financial, legal and accounting advisors, filings fees, printing expenses and other related costs. Some of these costs are payable by us regardless of whether the Merger is completed. If the Merger is not consummated, we may under certain circumstances be required to pay to Parent a termination fee of $115.9 million.

The Merger Agreement limits our ability to pursue alternatives to the Merger and may discourage other companies from trying to acquire us for greater consideration than what is specified in the Merger Agreement.

The Merger Agreement contains provisions that make it more difficult for us to sell our business to a company other than Parent. These provisions include restrictions on the Company’s solicitation of alternative acquisition proposals from third parties. Under the Merger Agreement, the Company is required to pay a termination fee equal to $115.9 million if the Merger Agreement is terminated under certain circumstances (including to accept a “Superior Acquisition Proposal” as defined in the Merger Agreement), which could deter other potential bidders from making an acquisition proposal for the Company prior to the consummation of the Merger and could impact the Company’s ability to engage in another transaction for up to twelve months if the Merger Agreement is terminated in certain circumstances.

We may be the target of lawsuits related to the Merger which could result in substantial costs and may delay or prevent the Merger from being completed.

Shareholder lawsuits are often brought against public companies that have entered into merger agreements. Even if these lawsuits are without merit, defending against these claims can result in substantial costs and divert management time and resources. Lawsuits filed in connection with the Merger against the Company and/or its directors and officers could prevent or delay the consummation of the Merger and result in additional costs to us. The ultimate resolution of any lawsuits cannot be predicted, and an adverse ruling in any such lawsuit may cause the Merger to be delayed or not to be completed, which could cause us not to realize some or all of the anticipated benefits of the Merger. We cannot currently predict the outcome of any lawsuits or claims.

Item 6.Exhibits

Exhibits required by Item 601 of Regulation S-K:


Exhibit						Description of Exhibit
10.1*2.1						Agreement and Plan of Merger, dated as of May 13, 2022, by and among Moose Bidco, Inc., Moose Merger Sub, Inc. and ManTech International Corporation ~~2022~~(incorporated herein by reference from registrants Current Report on Form 8-K, as filed with the SEC on May 16, 2022)
10.1 *						Form of Amendment to Executive Continuity and Stay Incentive ~~Compensation Plan, adopted on February 22, 2022, in which our executive officers participate~~Agreement (incorporated by reference from registrant's Current Report on Form 8-K, as filed with the SEC on ~~February 24, 2022).~~May 17, 2022.
31.1‡						Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
31.2‡						Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
32‡						Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended.
101.INS						Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH						Inline XBRL Taxonomy Extension Schema Document.
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*Management contract or compensatory plan or arrangement required to be filed as an Exhibit to this report pursuant to Item 15(a)(3).
‡ Filed herewith.

2227

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		MANTECH INTERNATIONAL CORPORATION

		By:	/s/ KEVIN M. PHILLIPS
Date:	~~May 5,~~August 3, 2022	Name:	Kevin M. Phillips
		Title:	Chairman, Chief Executive Officer and President


		By:	/s/ JUDITH L. BJORNAAS
Date:	~~May 5,~~August 3, 2022	Name:	Judith L. Bjornaas
		Title:	Chief Financial Officer

2328